- Home
- DYAI vs DARE Comparison
DYAI vs DARE Comparison
Compare DYAI & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYAI
- DARE
- Stock Information
- Founded
- DYAI 1979
- DARE 2015
- Country
- DYAI United States
- DARE United States
- Employees
- DYAI N/A
- DARE N/A
- Industry
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- DARE Biotechnology: Pharmaceutical Preparations
- Sector
- DYAI Health Care
- DARE Health Care
- Exchange
- DYAI Nasdaq
- DARE Nasdaq
- Market Cap
- DYAI 29.6M
- DARE 26.3M
- IPO Year
- DYAI 2004
- DARE N/A
- Fundamental
- Price
- DYAI $1.00
- DARE $2.63
- Analyst Decision
- DYAI Strong Buy
- DARE Strong Buy
- Analyst Count
- DYAI 1
- DARE 3
- Target Price
- DYAI $6.00
- DARE $12.50
- AVG Volume (30 Days)
- DYAI 38.9K
- DARE 34.9K
- Earning Date
- DYAI 08-12-2025
- DARE 08-11-2025
- Dividend Yield
- DYAI N/A
- DARE N/A
- EPS Growth
- DYAI N/A
- DARE N/A
- EPS
- DYAI N/A
- DARE N/A
- Revenue
- DYAI $3,554,344.00
- DARE $25,909.00
- Revenue This Year
- DYAI $22.56
- DARE $99,756.91
- Revenue Next Year
- DYAI $30.95
- DARE $119.77
- P/E Ratio
- DYAI N/A
- DARE N/A
- Revenue Growth
- DYAI 57.59
- DARE N/A
- 52 Week Low
- DYAI $0.91
- DARE $2.56
- 52 Week High
- DYAI $2.20
- DARE $5.64
- Technical
- Relative Strength Index (RSI)
- DYAI 49.34
- DARE 35.11
- Support Level
- DYAI $0.95
- DARE $2.56
- Resistance Level
- DYAI $1.06
- DARE $2.95
- Average True Range (ATR)
- DYAI 0.06
- DARE 0.13
- MACD
- DYAI 0.01
- DARE -0.06
- Stochastic Oscillator
- DYAI 56.67
- DARE 9.72
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.